Literature DB >> 3305726

Cell surface antigens on human marrow cells: dissection of hematopoietic development using monoclonal antibodies and multiparameter flow cytometry.

C I Civin, M R Loken.   

Abstract

A single sample of bone marrow includes the entire range of the developmental process, since cells of all stages and lineages are present. By selecting appropriate monoclonal antibodies, marrow cells of different lineages can be identified, even in their immature forms. Maturationally different bone marrow cells can be distinguished on the basis of their cell surface antigen expression and physical characteristics on a flow cytometer. Antigenic markers can be used within a lineage to trace the development from colony-forming cells to functional blood cells. Changes in cellular markers are observed as smooth, quantitative increases or decreases in cellular antigen expression. After defining the composition of normal marrow, it is possible to identify perturbations from the steady state and to monitor the return to homeostasis. Cells at various stages can be enumerated, then isolated for further study. In particular, these studies provide for the identification, purification and manipulation of the earliest hematopoietic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305726     DOI: 10.1002/stem.5530050403

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  7 in total

1.  Analysis of CD34-positive hemopoietic progenitor cells from normal human adult peripheral blood: flow-cytometrical studies and in-vitro colony (CFU-GM, BFU-E) assays.

Authors:  S Serke; S Säuberlich; Y Abe; D Huhn
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

2.  Expression of leukemia-associated antigen, JL1, in bone marrow and thymus.

Authors:  Y K Shin; E Y Choi; S H Kim; J Chung; D H Chung; W S Park; K C Jung; H S Kim; S Park; H J Kim; M H Park; C K Min; C C Kim; S H Park
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

3.  Clinical experience of clozapine-induced neutropenia in the UK. Laboratory investigation using liquid culture systems and immunofluorocytometry.

Authors:  P A Veys; S Wilkes; S Shah; R Noyelle; A V Hoffbrand
Journal:  Drug Saf       Date:  1992       Impact factor: 5.606

4.  Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3.

Authors:  C H Dai; S B Krantz; R T Means; S T Horn; H S Gilbert
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

5.  Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma.

Authors:  C Verfaillie; K Blakolmer; P McGlave
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

6.  Treatment with at homeopathic complex medication modulates mononuclear bone marrow cell differentiation.

Authors:  Beatriz Cesar; Ana Paula R Abud; Carolina C de Oliveira; Francolino Cardoso; Raffaello Popa Di Bernardi; Fernando S F Guimarães; Juarez Gabardo; Dorly de Freitas Buchi
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-17       Impact factor: 2.629

7.  Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531.

Authors:  Andrew P Voigt; Lisa Eidenschink Brodersen; Todd A Alonzo; Robert B Gerbing; Andrew J Menssen; Elisabeth R Wilson; Samir Kahwash; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Soheil Meshinchi; Denise A Wells; Michael R Loken
Journal:  Haematologica       Date:  2017-09-07       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.